https://adisinsight.springer.com/drugs/800078978?error=cookies_not_supported&code=7d2539a5-bfbe-4679-89e3-24962cf239d9
64Cu SAR bisRGD - AdisInsight
64Cu SAR bisRGD is a radiotherapeutic being developed by Clarity Pharmaceuticals for the diagnosis of cancer. It contains a peptide RGD, targeting the
saradisinsight
https://research.tudelft.nl/en/publications/application-of-64cu-in-copper-speciation-and-copper-speciation-ki/
Application of 64Cu in copper speciation and copper speciation kinetics - TU Delft Research Portal
https://profiles.wustl.edu/en/publications/sup64supcu-core-labeled-nanoparticles-with-high-specific-activity/
64Cu core-labeled nanoparticles with high specific activity via metal-free click chemistry -...
https://www.nist.gov/publications/standardization-64cu-activity
Standardization of 64Cu activity | NIST
Mar 12, 2020 - The complex decay scheme that makes 64Cu promising as both an imaging and therapeutic agent in medicine also makes the absolute measurement of its activity chal
standardizationactivitynist